These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 19825397)

  • 1. Coffee and liver diseases.
    Muriel P; Arauz J
    Fitoterapia; 2010 Jul; 81(5):297-305. PubMed ID: 19825397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modification of N-acetyltransferases and glutathione S-transferases by coffee components: possible relevance for cancer risk.
    Huber WW; Parzefall W
    Methods Enzymol; 2005; 401():307-41. PubMed ID: 16399395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coffee and liver health.
    Morisco F; Lembo V; Mazzone G; Camera S; Caporaso N
    J Clin Gastroenterol; 2014; 48 Suppl 1():S87-90. PubMed ID: 25291138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential chemoprotective effects of the coffee components kahweol and cafestol palmitates via modification of hepatic N-acetyltransferase and glutathione S-transferase activities.
    Huber WW; Teitel CH; Coles BF; King RS; Wiese FW; Kaderlik KR; Casciano DA; Shaddock JG; Mulder GJ; Ilett KF; Kadlubar FF
    Environ Mol Mutagen; 2004; 44(4):265-76. PubMed ID: 15468054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular Bases Underlying the Hepatoprotective Effects of Coffee.
    Salomone F; Galvano F; Li Volti G
    Nutrients; 2017 Jan; 9(1):. PubMed ID: 28124992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coffee, liver enzymes, cirrhosis and liver cancer.
    La Vecchia C
    J Hepatol; 2005 Apr; 42(4):444-6. PubMed ID: 15763323
    [No Abstract]   [Full Text] [Related]  

  • 7. Coffee and the liver: a potential treatment for liver disease?
    Masterton GS; Hayes PC
    Eur J Gastroenterol Hepatol; 2010 Nov; 22(11):1277-83. PubMed ID: 20802342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of the chemoprotective enzymes glucuronosyl transferase and glutathione transferase in specific organs of the rat by the coffee components kahweol and cafestol.
    Huber WW; Prustomersky S; Delbanco E; Uhl M; Scharf G; Turesky RJ; Thier R; Schulte-Hermann R
    Arch Toxicol; 2002 May; 76(4):209-17. PubMed ID: 12029384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coffee diterpenes prevent the genotoxic effects of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) and N-nitrosodimethylamine in a human derived liver cell line (HepG2).
    Majer BJ; Hofer E; Cavin C; Lhoste E; Uhl M; Glatt HR; Meinl W; Knasmüller S
    Food Chem Toxicol; 2005 Mar; 43(3):433-41. PubMed ID: 15680679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of coffee and its chemopreventive components kahweol and cafestol on cytochrome P450 and sulfotransferase in rat liver.
    Huber WW; Rossmanith W; Grusch M; Haslinger E; Prustomersky S; Peter-Vörösmarty B; Parzefall W; Scharf G; Schulte-Hermann R
    Food Chem Toxicol; 2008 Apr; 46(4):1230-8. PubMed ID: 17983700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An epidemiological study of the association of coffee with chronic liver disease.
    Walton HB; Masterton GS; Hayes PC
    Scott Med J; 2013 Nov; 58(4):217-22. PubMed ID: 24215040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coffee consumption and risk of liver cancer: a meta-analysis.
    Larsson SC; Wolk A
    Gastroenterology; 2007 May; 132(5):1740-5. PubMed ID: 17484871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental evidence for the protective effects of coffee against liver fibrosis in SD rats.
    Shin JW; Wang JH; Kang JK; Son CG
    J Sci Food Agric; 2010 Feb; 90(3):450-5. PubMed ID: 20355067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of cancer chemopreventive enzymes by coffee is mediated by transcription factor Nrf2. Evidence that the coffee-specific diterpenes cafestol and kahweol confer protection against acrolein.
    Higgins LG; Cavin C; Itoh K; Yamamoto M; Hayes JD
    Toxicol Appl Pharmacol; 2008 Feb; 226(3):328-37. PubMed ID: 18028974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of epoxidation and electrophile-responsive element-regulated gene transcription in the potentially beneficial and harmful effects of the coffee components cafestol and kahweol.
    van Cruchten ST; de Haan LH; Mulder PP; Kunne C; Boekschoten MV; Katan MB; Aarts JM; Witkamp RF
    J Nutr Biochem; 2010 Aug; 21(8):757-63. PubMed ID: 19616929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review article: possible beneficial effects of coffee on liver disease and function.
    Cadden IS; Partovi N; Yoshida EM
    Aliment Pharmacol Ther; 2007 Jul; 26(1):1-8. PubMed ID: 17555416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coffee and non-alcoholic fatty liver disease: brewing evidence for hepatoprotection?
    Chen S; Teoh NC; Chitturi S; Farrell GC
    J Gastroenterol Hepatol; 2014 Mar; 29(3):435-41. PubMed ID: 24199670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Coffee as hepatoprotective factor].
    Szántová M; Ďurkovičová Z
    Vnitr Lek; 2016; 62(12):990-997. PubMed ID: 28139128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of coffee on liver diseases: a systematic review.
    Saab S; Mallam D; Cox GA; Tong MJ
    Liver Int; 2014 Apr; 34(4):495-504. PubMed ID: 24102757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The multifaceted mechanisms for coffee's anti-tumorigenic effect on liver.
    Tao KS; Wang W; Wang L; Cao DY; Li YQ; Wu SX; Dou KF
    Med Hypotheses; 2008 Nov; 71(5):730-6. PubMed ID: 18701223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.